MAR: Selloff Overprices the Iran Headwind

A 33.6x P/E sounds rich until you remember what Marriott actually is: an asset-light royalty on global travel, generating fees from 9,000+ properties it doesn't own. The company carries negative book equity — a feature, not a bug, of a capital-return machine that has bought back stock aggressively for years. Traditional P/B metrics are meaningless here.

The real valuation lens is free cash flow. At $1.84–$3.50 FCF per share across the last four quarters, Marriott generates between $490M and $930M in annual free cash that it routes to buybacks and dividends. At $319.76, the stock trades at roughly 34x the low end of trailing FCF — which reflects the Q4 trough. Against normalized FCF at Q2/Q3 run rates, the multiple compresses to the low 20s.

Analyst consensus has revenue at roughly $6.70B per quarter by 2028 with EPS averaging $3.44 per quarter — implying full-year EPS north of $13. At $319.76, you're paying 24.5x 2028 earnings on a company with a genuine global moat. For a full framework on how to apply these multiples, see how to value a stock using PE, EV/EBITDA, and DCF. The market is acting as if Iran is a permanent demand suppressor. History of prior travel shocks — SARS, Gulf War II, COVID — suggests otherwise.

Marriott's negative book equity alarms first-time screeners. The balance sheet looks broken until you understand the model: Marriott earns management and franchise fees from properties it doesn't own, returning essentially all capital to shareholders. Negative equity is the mathematical result of aggressive buybacks — not financial distress.

The real health metrics are cash flow and interest coverage. Operating CF per share ranged $2.33–$4.02 across the four quarters. FCF per share: $1.84–$3.50. Interest coverage: 3.74x–6.09x. The low end of the coverage range (3.74x in Q4) is the number bears will cite. The Q2 peak of 6.09x shows what the business looks like in a normal quarter. At 3.74x in the seasonal trough, Marriott still covers its interest obligations with room to spare.

This is not a distressed balance sheet. It's a balance sheet engineered for capital efficiency. The company runs levered because equity is expensive and fee-stream debt is cheap. BBVA reducing its position by 18.4% is noise — institutional portfolio rebalancing happens constantly. The operating cash flow per share of $2.33–$4.02 is the number that matters.

The next earnings release is May 5, 2026. That's the first hard data on whether the Iran-driven travel selloff translated into actual RevPAR degradation or whether leisure and business travel stayed resilient. The Iran conflict has already pushed mortgage rates higher as inflation fears spread — but hotel demand and mortgage demand are different animals. Hotel stocks are already rebounding from the war-scare lows — the market is starting to price in the same conclusion the data suggests: geopolitical shocks are temporary demand deferral, not demand destruction.

The bull case is straightforward: Q1 2026 shows seasonal improvement from Q4, the St. Regis signing signals pipeline momentum, and Iran-driven travel fears fade as the conflict stabilizes. On that scenario, Marriott re-rates toward 28–30x forward earnings — implying a price in the $370–$400 range against $13+ in 2028 EPS.

The bear case: the Iran conflict escalates materially, global air travel contracts for multiple quarters, and RevPAR declines force margin compression across Marriott's entire franchise system. Even here, the asset-light model provides a buffer — Marriott's fee income doesn't collapse the way hotel owners' NOI does in a downturn.

At $319.76, the risk/reward favors the bull case. The stock is 14% off its high on news that historically reverses. The May 5 catalyst is the binary event. Position accordingly.